RxDoctor Payments DataLook up a doctor →

Amarilis Sanchez Valle, MD

Clinical Genetics (M.D.) · Tampa, FLNPI 1275841603

Payments from drug & device makers

$2,657,157in general payments, 2019–2025

Across 520 payments — averaging $5109.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biomarin Pharmaceutical Inc.$1.9M
  • Ultragenyx Pharmaceutical Inc.$623K
  • Amicus Therapeutics, Inc.$52K
  • Amgen$48K
  • AstraZeneca$34K
  • Recordati_rare_diseases_inc.$27K
  • plus $18K from 6 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,657,157 in reported general payments places this provider in the 95th percentile of 37 clinical genetics (m.d.) providers in Florida.

See all clinical genetics (m.d.) providers in Florida

Medicare billing

Part B allowed, 2024
$4,115
Medicare patients
14
Services billed
32

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical genetics (m.d.) in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →